Raphael Deferiere
Chief Accounting Officer
Centessa Pharmaceuticals plc (CNTA)Equibles does not estimate personal net worth.
Get an email with a short summary when Centessa Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get CNTA alertsAbout Raphael Deferiere
Raphael Deferiere is recorded as Chief Accounting Officer at Centessa Pharmaceuticals plc (CNTA). The newest filing on record that lists Raphael Deferiere as Chief Accounting Officer at Centessa Pharmaceuticals plc (CNTA) is dated April 29, 2026. Centessa Pharmaceuticals plc reported in an 8-K filed June 24, 2026 that Raphael Deferiere was terminated as Executive Officer, effective June 24, 2026. Centessa Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Centessa Pharmaceuticals plc includes Mario Alberto Accardi (CEO and Board Member), Francesco De Rubertis (Chairman), John Crowley (CFO) and 7 others.
“Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 29, 2026
Company network
Leadership on record at Centessa Pharmaceuticals plc
- Mario Alberto Accardi CEO, Board Member
- Francesco De Rubertis Chairman
- John Crowley CFO
- Thomas Templeman CTO
- Iqbal Hussain General Counsel
- Gregory Weinhoff Chief Accounting Officer
- Gregory Weinhoff, M.D., M.B.A. Chief Accounting Officer
- Raphael Deferiere, CPA Chief Accounting Officer
- Christopher Stokes Board Member
- Kristina Mignon Wright Board Member